19 June 2023 - Ibrutinib (Imbruvica)140 mg, 280 mg & 420 mg tablets are now subsidised for the treatment ...
29 April 2020 - TLV has developed a health economic knowledge base for the regions of the drug Keytruda (pembrolizumab). ...